GSK plc GSK NYSE

GSK plc (GSK) reported total assets of $61.01B and total liabilities of $45.02B for quarter ending 2025-12-31, resulting in total equity of $15.93B.

The company held $3.4B in cash and short-term investments. Total debt stood at $17.69B, with net debt of $14.3B. The Debt-to-Equity (D/E) ratio was 1.11 (moderate).

Current ratio is 0.82, which may signal tight short-term liquidity. Interest coverage is 5.9x (adequate).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (90/100) — Total assets $61.01B and equity $15.93B support the company's competitive scale
• VALUE (49/100) — Debt-to-Equity 1.11 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 64/100 with 4/7 criteria passed.